cupure logo

Intisomeran News

Moderna and Merck's mRNA Cancer Vaccine Shows Promise in Melanoma Trials

Moderna cancer vaccine cuts melanoma relapse risk

Intisomeran is a personalized mRNA cancer vaccine developed by Moderna and Merck for melanoma treatment.